Scientists who laid groundwork for weight-loss drugs win Lasker medical award
While the GLP-1 treatments worked well in experiments on ... the weight-loss medication market could reach $100 billion by ...
China-born Chen Zhijian wins top US medical research prize said to foretell Nobel
The Lasker-DeBakey Award for clinical medical research went to three scientists for their work on GLP-1, the hormone that led ...
AFP on MSN1mon
The winding, fitful path to weight loss drug Ozempic
Joel Habener of Massachusetts General Hospital and Svetlana Mojsov of The Rockefeller University, who are being honored with ...
Medscape12d
GLP-1 RAs Reduce Early-Onset Colorectal Cancer Risk in Patients With Type 2 Diabetes
PHILADELPHIA — The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with a significant decrease in the risk for early-onset colorectal cancer (EO-CRC) in patients with ...
U.S. News & World Report16d
Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds
Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds By Ernie Mundell HealthDay Reporter FRIDAY, Oct. 25, 2024 (HealthDay News) -- As the popularity of GLP-1 meds like Wegovy and ...
How weight-loss drugs Ozempic and Wegovy were developed and the scientists behind them
Starting in the 1990s, Knudsen, the head of GLP-1 therapeutics at Novo Nordisk, and her team built on these breakthroughs to ...